OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Weight loss strategies, weight change, and type 2 diabetes in US health professionals: A cohort study
Keyi Si, Yang Hu, Molin Wang, et al.
PLoS Medicine (2022) Vol. 19, Iss. 9, pp. e1004094-e1004094
Open Access | Times Cited: 15

Showing 15 citing articles:

Efficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials
Yasmin Mesquita, Izabela Pera Calvi, Isabela Reis Marques, et al.
International Journal of Obesity (2023) Vol. 47, Iss. 10, pp. 883-892
Closed Access | Times Cited: 29

Features, functions, and associated diseases of visceral and ectopic fat: a comprehensive review
Jiaqiang Luo, Yi Wang, Jinyuan Mao, et al.
Obesity (2025)
Closed Access

Weight Gain, Weight Loss, and Type 2 Diabetes Risk: Evidence From the Atherosclerosis Risk in Communities (ARIC) Study
Samaneh Asgari, Soroush Masrouri, Leila Molaeipour, et al.
Endocrinology Diabetes & Metabolism (2025) Vol. 8, Iss. 3
Open Access

Weight loss and risk of dementia in individuals with versus without obesity
Keun You Kim, Jung-Hee Ha, Jun‐Young Lee, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 12, pp. 5471-5481
Open Access | Times Cited: 7

Low-Carbohydrate Diet Macronutrient Quality and Weight Change
Binkai Liu, Yang Hu, K. Sharan, et al.
JAMA Network Open (2023) Vol. 6, Iss. 12, pp. e2349552-e2349552
Open Access | Times Cited: 7

JAK1/2 Regulates Synergy Between Interferon Gamma and Lipopolysaccharides in Microglia
A. P. Young, Eileen M. Denovan‐Wright
Journal of Neuroimmune Pharmacology (2024) Vol. 19, Iss. 1
Closed Access | Times Cited: 2

DPP-IV as a potential candidate in anti-obesity and obesity-related diseases treatment
Xin Guo, Huolun Feng, Liyang Cai, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117464-117464
Open Access | Times Cited: 2

Should Pharmaceuticals Be Used as Weight Loss Interventions for Adolescents Classified as Obese by BMI?
Astrid Floegel‐Shetty
The AMA Journal of Ethic (2023) Vol. 25, Iss. 7, pp. E478-495
Open Access | Times Cited: 5

Weight Loss Versus Glycemic Control as the Primary Treatment Target in Newly Diagnosed Type 2 Diabetes: Why Choose When You Can Have Both?
Theocharis Koufakis, Evangelos Liberopoulos, Alexander Kokkinos, et al.
Drugs (2023) Vol. 83, Iss. 6, pp. 469-477
Closed Access | Times Cited: 4

“Does Physical Exercise Promote Health Benefits for Diabetic Patients during the COVID-19 Pandemic?”: A Systematic Review
Erivaldo de Souza, Daniela Meneses Santos, JOSUÉ CRUZ DOS SANTOS, et al.
Sports (2023) Vol. 11, Iss. 10, pp. 192-192
Open Access | Times Cited: 2

The Effect of Baseline Thyroid Function on Weight Loss Outcomes in Euthyroid Individuals Undergoing Full Meal Replacement Therapy
Robert Dent, Ran Cheng, Alexandra Bussières, et al.
Research Square (Research Square) (2024)
Closed Access

The vices and virtues of medical models of obesity
Jonathan Sholl, Andreas De Block
Obesity Reviews (2024) Vol. 25, Iss. 12
Open Access

Page 1

Scroll to top